NFKB1 and acute myeloid leukemia: As reported in the literature, a subset of AMLs is characterized by secretion of high levels of pro-inflammatory cytokines, that in turn activate NF-κB pathway, thus generating a positive feedback loop able to sustain NF-κB-dependent AML growth both in patients and in murine models [18].